Hypovitaminosis D in geriatric inpatients: A marker of severity of chronic diseases

Aging Clinical and Experimental Research

Volumn 24, Issue 2, 2012, Pages 188-192

  Beauchet, Olivier ^a,b   Hélard, Lise ^a,b   Montero Odasso, Manuel ^c   De Decker, Laure ^d   Berrut, Gilles ^d   Annweiler, Cédric ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITÉ DE NANTES   (France)

Author keywords

Chronic diseases; Morbidity burden; Older adults; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE;

AGE; AGED; ARTICLE; CAUCASIAN; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGE FACTORS; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; GERIATRICS; HUMANS; INPATIENTS; MALE; PARATHYROID HORMONE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84864521176     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Souberbielle JC, Friedlander G, Kahan A, Cormier C. Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 2006; 73: 249-53.
2. Annweiler C, Montero-Odasso M, Schott AM, Berrut G, Fantino B, Beauchet O. Fall prevention and vitamin D in the elderly: an overview of the key role of the non-bone effects. J Neuroeng Rehabil 2010; 7: 50.
3. Dawson-Hughes B, Heaney R, Holick M, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-6. (Pubitemid 40933586)
4. Sutra del Galy A, Bertrand M, Bigot F et al. Vitamin D insufficiency and acute care in geriatric inpatients. J Am Geriatr Soc 2009; 57: 1721-3.
5. Annweiler C, Pochic S, Fantino B et al. Serum vitamin D concentration and short-term mortality among geriatric inpatients in acute care settings. Adv Ther 2010; 27: 245-9.
6. Peterlik M, Cross HS. Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr 2009; 63: 1377-86.
7. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009; 7: 357-63.
8. Covinsky KE, Palmer RM, Fortinsky RH et al. Loss of independence in activities of daily living in older adults hospitalized with medical illness: increased vulnerability with age. J Am Geriatr Soc 2003; 51: 451-8. (Pubitemid 36457342)
9. Meier DS, Balashov KE, Healy B, Weiner HL, Guttmann CR. Seasonal prevalence of MS disease activity. Neurology 2010; 75: 799-806.
10. Oh EY, Ansell C, Nawaz H, Yang CH, Wood PA, Hrushesky WJ. Global breast cancer seasonality. Breast Cancer Res Treat 2010; 123: 233-43.
11. Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974; 27: 387-404.
12. Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine 1990; 69: 1-33. (Pubitemid 20062024)
13. Harboun M, Ankri J. Comorbidity indexes: review of the literature and application to studies of elderly population. Rev Epidemiol Sante Publique 2001; 49: 287-98. (Pubitemid 32702823)
14. Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O. Vitamin D in the elderly: 5 points to remember. Geriatr Psychol Neuropsychiatr Vieil 2011; 9: 259-67.
15. Anderson GF. Medicare and chronic conditions. N Engl J Med 2005; 353: 305-9. (Pubitemid 41058333)
16. Reuben DB. Better care for older people with chronic diseases: an emerging vision. JAMA 2007; 298: 2673-4. (Pubitemid 350254961)
17. Annweiler C, Le Gall D, Fantino B, Beauchet O, Tucker KL, Buell JS. 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010; 75: 95.
18. Schumock GT, Andress D, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K. Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in predialysis CKD patients. Curr Med Res Opin 2008; 24: 3037-48.
19. Fisher AA, Southcott EK, Srikusalanukul W et al. Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci 2007; 37: 222-32. (Pubitemid 47311338)
20. Yu N, Donnan PT, Flynn RW et al. Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 2010; 73: 30-4.